<DOC>
	<DOC>NCT02155712</DOC>
	<brief_summary>The success rate of the Triathlon Tritanium Knee, defined as absence of revision for aseptic loosening of the tibial baseplate at 2 years, is no worse than rates reported in the literature for cemented devices.</brief_summary>
	<brief_title>Triathlon Tritanium Knee Outcomes Study</brief_title>
	<detailed_description />
	<criteria>1. Patient has signed an Institutional Review Board (IRB)/Ethics Committee (EC) approved; study specific Informed Patient Consent Form. 2. Patient is a male or nonpregnant female age 1875 years at time of study device implantation. 3. Patient has a diagnosis of NonInflammatory Degenerative Joint Disease (NIDJD). 4. Patient is a candidate for primary cementless total knee replacement, including a resurfaced patella. 5. Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. 1. Patient has a Body Mass Index (BMI) &gt; 40. 2. Patient has a diagnosis of avascular necrosis or inflammatory arthritis. 3. Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation. 4. Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device. 5. Subject is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration. 6. Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. &gt; 30 days). 7. Patient is diagnosed with lumbar radicular pain. 8. Patient has a known sensitivity to device materials. 9. Patient is a prisoner.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>